CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed
Drug / intervention
Vitatron biventricular pacemakerdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00156728
NCT00156728Phase 4Completed
CompareCT.gov

Congestive Heart Failure Atrial Arrhythmia Monitoring and Pacing (CHAMP)

Medtronic BRC·interventional·Posted Sep 12, 2005·Updated Nov 4, 2008

In Brief

A Phase 4 clinical trial evaluating Vitatron biventricular pacemaker for Congestive Heart Failure, Atrial Fibrillation. Completed, across 23 sites in 7 countries.

Detailed Summary

The purpose of the study is to characterize atrial arrhythmias in patients indicated for Cardiac Resynchronization Therapy (CRT) and to monitor changes in atrial arrhythmias while CRT is provided.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCongestive Heart Failure, Atrial Fibrillation
CountriesCzechia, France, Italy, Netherlands, Serbia, Slovakia, United Kingdom
Collaborators--

Timeline

Phase 4CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 12, 2005
Enrollment StartOct 1, 2003
Study CompletionDec 1, 2005
TodayJul 2, 2026
Posted 20.8 years ago

Interventions

Vitatron biventricular pacemakerdevice